AlloVir Inc

NASDAQ:ALVR   3:59:42 PM EDT
23.71
-0.29 (-1.21%)
Products

Allovir Announces FDA Clearance Of IND Application For ALVR109

Published: 09/17/2020 15:20 GMT
AlloVir Inc (ALVR) - Allovir Announces the FDA Clearance of Investigational New Drug Application (ind) for Alvr109 for the Treatment of High-risk Covid-19 Patients.
Allovir Inc - Proof-of-concept Clinical Trial With Alvr109 to Begin in Q42020.